Obid, Laihana .

HRN: 24-46-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2026
CEFUROXIME 750MG (VIAL)
08/03/2026
08/06/2026
IVT
750MG
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: